维普中文期刊产品整合服务
4篇 您的检索式:作者名="K.Perry"
    题名 作者 年代 出处 被引量
1Two Novel Assays of Alloantibody‐Secreting Cells Demonstrating Resistance to Desensitization With IVIG and rATG显示文摘D. K.Perry H. S.Pollinger J. M.Burns D.Rea E.Ramos J. L.Platt J. M.Gloor M. D.Stegall 2007American Journal of Transplantation2007,,1:1
2Alloantibody Levels and Acute Humoral Rejection Early After Positive Crossmatch Kidney Transplantation显示文摘J. M.Burns L. D.Cornell D. K.Perry H. S.Pollinger J. M.Gloor W. K.Kremers M. J.Gandhi P. G.Dean M. D.Stegall 2008American Journal of Transplantation2008,,12:1
3Medicinal Plants and Alzheimer’s Disease: from Ethnobotany to Phytotherapy**显示文摘ELAINE K.PERRY ANNE T.PICKERING WEI WEIWANG PETER J.HOUGHTON NICOLETTE S. L.PERRY 2010Journal of Pharmacy and Pharmacology2010,,:1
4Targeting growth hormone function: strategies and therapeutic applications显示文摘Human growth hormone(GH)is a classical pituitary endocrine hormone that is essential for normal postnatal growth and has pleiotropic effects across multiple physiological systems.GH is also expressed in extrapituitary tissues and has localized autocrine/paracrine effects at these sites.In adults,hypersecretion of GH causes acromegaly,and strategies that block the release of GH or that inhibit GH receptor(GHR)activation are the primary forms of medical therapy for this disease.Overproduction of GH has also been linked to cancer and the microvascular complications that are associated with diabetes.However,studies to investigate the therapeutic potential of GHR antagonism in these diseases have been limited,most likely due to difficulty in accessing therapeutic tools to study the pharmacology of the receptor in vivo.This review will discuss current and emerging strategies for antagonizing GH function and the potential disease indications.Man Lu Jack U.Flanagan Ries J.Langley Michael P.Hay Jo K.Perry 2019Signal Transduction and Targeted Therapy2019,4,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费